Possible scenario
FDA Link Holds
40% Chance
The FDA's traceback case remains the central finding despite Mexico's objections. U.S. and Mexican officials continue technical talks, but the practical outcome is a targeted recall, supplier remediation, and litigation risk focused on Taylor Farms rather than a broad food-trade dispute.
Secondary impacts
- Consumer Non-Cyclicals -0.3%
Portfolio impact
S&P 500-0.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.